血液遗传学专栏
ENGLISH ABSTRACT
新等位基因 HLA-DRB1*12:106 1例的确认
董丽娜
陈男英
何亿镇
章伟
朱发明
作者及单位信息
·
DOI: 10.3760/cma.j.cn511374-20240627-00355
Identification of a case with novel HLA-DRB1*12: 106 allele
Dong Li′na
Chen Nanying
He Yizhen
Zhang Wei
Zhu Faming
Authors Info & Affiliations
Dong Li′na
Blood Center of Zhejiang Province, Hangzhou, Zhejiang 310052, China
Chen Nanying
Blood Center of Zhejiang Province, Hangzhou, Zhejiang 310052, China
He Yizhen
Blood Center of Zhejiang Province, Hangzhou, Zhejiang 310052, China
Zhang Wei
Blood Center of Zhejiang Province, Hangzhou, Zhejiang 310052, China
Zhu Faming
Blood Center of Zhejiang Province, Hangzhou, Zhejiang 310052, China
·
DOI: 10.3760/cma.j.cn511374-20240627-00355
0
0
0
0
0
0
PDF下载
APP内阅读
摘要

目的鉴定 HLA新等位基因 HLA-DRB1*12:106的核苷酸序列。

方法以1名浙江省血液中心2023年入库检测的血小板献血者为研究对象,用基于AllType NGS 11位点、AllType FASTplex NGS试剂的二代测序以及Sanger测序方法对其进行 HLA基因分型。用uTYPE 7.3和TypeStream Visual 3.0软件分别判定两种测序方法提示的献血者 HLA基因型。本研究通过了浙江省血液中心伦理委员会的审查(批准号:省血液中心伦审2022年研第001号)。

结果发现献血者携带1个 HLA-DRB1*12新等位基因,将其全部编码序列(801 bp)提交GenBank数据库(编号为OR101190)。该序列被世界卫生组织 HLA系统因子命名委员会正式命名为 HLA-DRB1*12:106(提交编号为HWS10066755)。与其同源性最高的 HLA-DRB1*12:01:01:01等位基因序列相比, HLA-DRB1*12:106第2外显子第344位的碱基T变异为G,导致第86位的缬氨酸替换为甘氨酸。献血者的 HLA基因型被确定为 HLA-A*02:01,11:01;-B*13:02,40:01;-C*01:02,03:03;-DRB1*07:01,12:106;-DRB3*01:01;-DRB4*01:03;-DQA1*02:01,04:01;-DQB1*02:02,04:02;-DPA1*01:03,01:03;-DPB1*02:01:02G,04:01:01G

结论在中国人群中确认了1个新的 HLA-DRB1等位基因,其变异氨基酸位于β链的肽结合区,可能影响潜在抗原肽的结合特性。

HLA-DRB1基因 ;二代测序;Sanger测序
ABSTRACT

ObjectiveTo identify the nucleotide sequence of a novel HLA-DRB1*12: 106 allele.

MethodsA blood donor who was joined into the database for platelet matching transfusion at the Blood Center of Zhejiang Province in 2023 was selected as the study subject. HLA genotyping was carried out through next-generation sequencing based on AllType NGS 11 locus, AllType FASTPlex NGS reagents, and Sanger sequencing method. The HLA genotype of the donor by Sanger sequencing and next generation sequencing were assigned by using uTYPE 7.3 and TypeStream Visual 3.0 software, respectively. This study was approved by Medical Ethics Committee of the Zhejiang Blood Center (Ethics No. Provincial Blood Center Ethics Review 2022 Research No. 001).

ResultsA novel HLA-DRB1*12 allele has been identified, and the full coding sequence has been submitted to the GenBank database (No. OR101190), and the length of submitted sequence was 801 bp, which was officially named as HLA-DRB1*12: 106 by the WHO Nomenclature Committee for Factors of the HLA System (submission No. HWS10066755). Compared with the sequence of the highest homology ( HLA-DRB1*12: 01: 01: 01 allele), a single nucleotide change was identified at position 344 T>G in the exon 2 of the HLA-DRB1*12: 106, which has resulted in replacement of Valine by Glycine at residue 86. The HLA genotype of the proband was determined as HLA-A*02: 01, 11: 01; -B*13: 02, 40: 01; -C*01: 02, 03: 03; -DRB1*07: 01, 12: 106; -DRB3*01: 01; -DRB4*01: 03; -DQA1*02: 01, 04: 01; -DQB1*02: 02, 04: 02; -DPA1*01: 03, 01: 03; -DPB1*02: 01: 02G, 04: 01: 01G.

ConclusionA novel HLA-DRB1 allele has been identified in the Chinese population. The mutated amino acid, located in the peptide binding region of the β chain, may affect the binding characteristics of antigen peptides.

HLA-DRB1 gene ;Next generation sequencing;Sanger sequencing
Zhu Faming, Email: mocdef.labiamtoh00mfz
引用本文

董丽娜,陈男英,何亿镇,等. 新等位基因 HLA-DRB1*12:106 1例的确认 [J]. 中华医学遗传学杂志,2025,42(02):151-155.

DOI:10.3760/cma.j.cn511374-20240627-00355

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
人类白细胞抗原(human leucocyte antigen, HLA)基因分型被广泛用于造血干细胞捐献者资料库建立、供受者 HLA配合选择、血小板配合性输注的献血者资料库建立以及疾病诊断等 [ 1 , 2 , 3 ]HLA-DRB1属于经典的 HLA-Ⅱ类基因,也是 HLA-Ⅱ类区域多态性最丰富的基因,编码HLA-DR抗原的β链,对造血干细胞/器官移植、病毒感染、糖尿病易感性等方面具有重要的参考价值 [ 4 , 5 , 6 , 7 ]HLA-DRB1*11等位基因可作为输血依赖性地中海贫血患者同种抗体产生的预测因子 [ 8 ]HLA-DRB1*12等位基因可能对乙肝病毒感染具有保护作用 [ 9 ],而某些 HLA-DRB1等位基因则与1型糖尿病的易感性显著相关 [ 10 ]HLA-DRB1基因全长约13 kb,共包含6个外显子,编码序列长度为801 bp,其中第1外显子编码前导肽,第2、3外显子编码DR抗原β链的β1和β2胞外结构域,第4外显子编码跨膜区结构域,第5、6外显子编码细胞质尾部 [ 11 ]。HLA-DR抗原特异性主要由 HLA-DRB1基因的第2外显子决定,后者编码多肽结合区,又称抗原识别功能区(antigen recognition domain,ARD)。随着测序技术的发展,已发现的 HLA-DRB1等位基因不断增加 [ 12 ]。本研究发现了1个变异在第2外显子的 HLA-DRB1新等位基因,并用不同的测序方法对其进行了确认,具体报告如下。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Mangum DS , Caywood E . A clinician′s guide to HLA matching in allogeneic hematopoietic stem cell transplant[J]. Hum Immunol, 2022,83(10):687-694. DOI: 10.1016/j.humimm.2022.03.002 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Chen N , Wang F , Zhao Y ,et al. HLA-A*02:06 allele may be susceptible to myelodysplastic syndrome in Zhejiang Han population, China [J]. Int J Immunogenet, 2023,50(5):233-242. DOI: 10.1111/iji.12629 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
何吉血小板配型及相容性输注的专家共识[J]. 浙江医学 2021,43(13):1367-1371. DOI: 10.12056/j.issn.1006-2785.2021.43.13.2021-1529 .
返回引文位置Google Scholar
百度学术
万方数据
He J . Expert consensus on the platelet matching and compatible transfusion[J]. Zhejiang Med, 2021,43(13):1367-1371. DOI: 10.12056/j.issn.1006-2785.2021.43.13.2021-1529 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[4]
Crocchiolo R , Rombolà G . Human leucocyte antigen system and selection of unrelated hematopoietic stem cell donors: impact of patient-donor (mis)matching and new challenges with the current technologies[J]. J Clin Med, 2023,12(2):646. DOI: 10.3390/jcm12020646 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Geo JA , Ameen R , Al Shemmari S ,et al. Advancements in HLA typing techniques and their impact on transplantation medicine [J]. Med Princ Pract, 2024,33(3):215-231. DOI: 10.1159/000538176 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Wang T , Shen C , Qi J ,et al. Haplotype-dependent HLA-DRB1-DQB1 susceptibility to occult HBV infection in Xi′an Han population [J]. Mol Genet Genomic Med, 2023,11(4):e2102. DOI: 10.1002/mgg3.2102 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Besanon S , Govender D , <x>Si</x> <x>dibé</x> AT ,et al. Clinical features, biochemistry, and HLA-DRB1 status in youth-onset type 1 diabetes in Mali [J]. Pediatr Diabetes, 2022,23(8):1552-1559. DOI: 10.1111/pedi.13411 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Ebrahimi M , Maleknia M , Parav N ,et al. The HLA-DRB1*11 group-specific allele is a predictor for alloantibody production in the transfusion-dependent thalassemia patients [J]. Transfus Apher Sci, 2020,59(3):102729. DOI: 10.1016/j.transci.2020.102729 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Zongo SV , Djigma FW , Yonli AT ,et al. Association of DRB1*11 and DRB1*12 alleles of the HLA system with the evolution of the Hepatitis B virus infection in Burkina Faso [J]. Mol Biol Rep, 2023,50(6):5039-5047. DOI: 10.1007/s11033-023-08353-0 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Khdair SI , Jarrar W , Jarrar YB ,et al. Association of HLA-DRB1 and - DQ alleles and haplotypes with type 1 diabetes in Jordanians [J]. Endocr Metab Immune Disord Drug Targets, 2020,20(6):895-902. DOI: 10.2174/1871530319666191119114031 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Hassan MM , Hussain MA , Ali SS ,et al. Detection of nonsynonymous single variants in human HLA-DRB1 exon 2 associated with renal transplant rejection [J]. Medicina (Kaunas), 2023,59(6):1116. DOI: 10.3390/medicina59061116 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Tran JN , Sherwood KR , Mostafa A ,et al. Novel alleles in the era of next-generation sequencing-based HLA typing calls for standardization and policy [J]. Front Genet, 2023,14:1282834. DOI: 10.3389/fgene.2023.1282834 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Hu T , Chitnis N , Monos D ,et al. Next-generation sequencing technologies: an overview[J]. Hum Immunol, 2021,82(11):801-811. DOI: 10.1016/j.humimm.2021.02.012 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Bruijnesteijn J . HLA/MHC and KIR characterization in humans and non-human primates using Oxford Nanopore Technologies and Pacific Biosciences sequencing platforms[J]. HLA, 2023,101(3):205-221. DOI: 10.1111/tan.14957 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Barker DJ , Maccari G , Georgiou X ,et al. The IPD-IMGT/HLA database[J]. Nucleic Acids Res, 2023,51(D1):D1053-D1060. DOI: 10.1093/nar/gkac1011 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
朱发明毛伟张志欣. 血小板配合性输注的分析和展望[J]. 中国输血杂志 2022,35(11):1097-1100. DOI: 10.13303/j.cjbt.issn.1004-549x.2022.11.001 .
返回引文位置Google Scholar
百度学术
万方数据
Zhu FM , Mao W , Zhang ZX . Analysis and prospect of platelet compatible transfusion[J]. Chin J Blood Transfus, 2022,35(11):1097-1100. DOI: 10.13303/j.cjbt.issn.1004-549x.2022.11.001 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[17]
赵烁贤董丽娜王芳. 基于Ion Torrent S5平台的二代测序技术对 HLA-DRB1 基因分型模棱两可进行分析 [J]. 中国卫生检验杂志 2021,31(2):195-198.
返回引文位置Google Scholar
百度学术
万方数据
Zhao SX , Dong LN , Wang F ,et al. Analyze the ambiguous results of HLA-DRB1 genotyping using NGS method based on the Ion Torrent S5 platform [J]. Chin J Health Lab Tec, 2021,31(2):195-198.
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[18]
董丽娜王芳章伟. TypeStream Visual软件在浙江汉族人群 HLA 分型结果指定的情况分析 [J]. 中国卫生检验杂志 2022,32(02):146-151.
返回引文位置Google Scholar
百度学术
万方数据
Dong LN , Wang F , Zhang W ,et al. Application analysis of TypeStream Visual software for HLA genotype assignment in Han Population in Zhejiang Province [J]. Chin J Health Lab Tec, 2022,32(02):146-151.
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[19]
Balassa K , Andrikovics H , Remenyi P ,et al. The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy [J]. Bone Marrow Transplant, 2015,50(10):1321-1325. DOI: 10.1038/bmt.2015.161 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Hamidpour M , Roshandel E , Ghaffari Nazari H ,et al. Association between human leukocyte antigens and graft-versus-host disease occurrence in allogeneic hematopoietic stem cell transplantation - a 10-year experience on Iranian patients[J]. Arch Iran Med, 2022,25(12):798-806. DOI: 10.34172/aim.2022.125 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
Tie R , Zhang T , Yang B ,et al. Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis [J]. Oncotarget, 2017,8(16):27645-27660. DOI: 10.18632/oncotarget.15291 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
朱发明,Email: mocdef.labiamtoh00mfz
B

董丽娜:实施研究、分析/解释数据、起草文章、获取研究经费;陈男英:实施研究、分析/解释数据;何亿镇:实施研究、采集数据、统计分析;章伟:酝酿和设计实验、分析/解释数据、行政/技术/材料支持;朱发明:酝酿和设计实验、起草文章、批评性审阅、指导

C
所有作者均声明不存在利益冲突
D
浙江省医药卫生科技计划项目 (2022KY733、2024KY939)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号